These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22812258)

  • 1. [Preparation and quality control of pyridostigmine bromide orally disintegrating tablet].
    Zhang L; Tan QY; Cheng XG; Wang H; Hu NN; Zhang JQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):458-61, 477. PubMed ID: 22812258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation.
    Tan Q; Zhang L; Liu G; He D; Yin H; Wang H; Wu J; Liao H; Zhang J
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1364-71. PubMed ID: 22994163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
    Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
    J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of an economic taste-masked dispersible tablet of pyridostigmine bromide, a highly soluble drug with an extremely bitter taste.
    Tan Q; Zhang L; Zhang L; Teng Y; Zhang J
    Chem Pharm Bull (Tokyo); 2012; 60(12):1514-21. PubMed ID: 23207632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
    Ge Z; Yang M; Wang Y; Shan L; Gao C
    Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged release matrix tablet of pyridostigmine bromide: formulation and optimization using statistical methods.
    Bolourchian N; Rangchian M; Foroutan SM
    Pak J Pharm Sci; 2012 Jul; 25(3):607-16. PubMed ID: 22713949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
    Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polymer, plasticizer and filler on orally disintegrating film.
    Liew KB; Tan YT; Peh KK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):110-9. PubMed ID: 23311593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
    Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
    Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taste masking microspheres for orally disintegrating tablets.
    Xu J; Bovet LL; Zhao K
    Int J Pharm; 2008 Jul; 359(1-2):63-9. PubMed ID: 18455893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
    Sammour OA; Hammad MA; Megrab NA; Zidan AS
    AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability.
    Tan QY; Hu NN; Liu GD; Yin HF; Zhang L; Wang H; Lu LY; Zhang JQ
    Arch Pharm Res; 2012 Mar; 35(3):499-508. PubMed ID: 22477197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
    Rahman Z; Siddiqui A; Khan MA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution testing of orally disintegrating tablets.
    Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
    J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride.
    Hu X; Li Y; Zhang E; Wang X; Xing M; Wang Q; Lei J; Huang H
    AAPS PharmSciTech; 2013 Mar; 14(1):29-37. PubMed ID: 23180226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of poly(lactic acid) nanoparticles for sustained release of pyridostigmine bromide.
    Tan QY; Xu ML; Wu JY; Yin HF; Zhang JQ
    Pharmazie; 2012 Apr; 67(4):311-8. PubMed ID: 22570937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosized sustained-release pyridostigmine bromide microcapsules: process optimization and evaluation of characteristics.
    Tan Q; Jiang R; Xu M; Liu G; Li S; Zhang J
    Int J Nanomedicine; 2013; 8():737-45. PubMed ID: 23459707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Technical scheme of real-time evaluation of traditional Chinese medicine orally disintegrating tablets].
    Qin D; Chen XD; Feng L; Gu JF; Yuan JR; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(24):4716-22. PubMed ID: 25898566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.